These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 30352379)

  • 1. Multifunctional approaches utilizing polymeric micelles to circumvent multidrug resistant tumors.
    Kesharwani SS; Kaur S; Tummala H; Sangamwar AT
    Colloids Surf B Biointerfaces; 2019 Jan; 173():581-590. PubMed ID: 30352379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming multiple drug resistance in cancer using polymeric micelles.
    Kesharwani SS; Kaur S; Tummala H; Sangamwar AT
    Expert Opin Drug Deliv; 2018 Nov; 15(11):1127-1142. PubMed ID: 30324813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the viability of Soluplus® self-assembled nanocolloids for sustained delivery of highly hydrophobic lapatinib (anticancer agent): Optimisation and in-vitro characterisation.
    Bonde GV; Ajmal G; Yadav SK; Mittal P; Singh J; Bakde BV; Mishra B
    Colloids Surf B Biointerfaces; 2020 Jan; 185():110611. PubMed ID: 31704609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
    Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X
    Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
    Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z
    J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
    Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
    Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimuli-responsive polymeric micelles for drug delivery and cancer therapy.
    Zhou Q; Zhang L; Yang T; Wu H
    Int J Nanomedicine; 2018; 13():2921-2942. PubMed ID: 29849457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.
    Milane L; Ganesh S; Shah S; Duan ZF; Amiji M
    J Control Release; 2011 Oct; 155(2):237-47. PubMed ID: 21497176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
    Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo.
    Wang J; Li Y; Wang L; Wang X; Tu P
    Drug Deliv; 2018 Nov; 25(1):330-340. PubMed ID: 29350064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance.
    Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T
    J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(D,L-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor.
    Zhao Y; Zhou Y; Wang D; Gao Y; Li J; Ma S; Zhao L; Zhang C; Liu Y; Li X
    Acta Biomater; 2015 Apr; 17():182-92. PubMed ID: 25612838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transferrin receptor-targeted pH-sensitive micellar system for diminution of drug resistance and targetable delivery in multidrug-resistant breast cancer.
    Gao W; Ye G; Duan X; Yang X; Yang VC
    Int J Nanomedicine; 2017; 12():1047-1064. PubMed ID: 28223798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox-sensitive mPEG-SS-PTX/TPGS mixed micelles: An efficient drug delivery system for overcoming multidrug resistance.
    Zhao D; Zhang H; Yang S; He W; Luan Y
    Int J Pharm; 2016 Dec; 515(1-2):281-292. PubMed ID: 27746331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copolymers: efficient carriers for intelligent nanoparticulate drug targeting and gene therapy.
    Hamidi M; Shahbazi MA; Rostamizadeh K
    Macromol Biosci; 2012 Feb; 12(2):144-64. PubMed ID: 22006795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of stimuli-responsive intelligent polymer micelles for the delivery of doxorubicin.
    Yang F; Xu J; Fu M; Ji J; Chi L; Zhai G
    J Drug Target; 2020 Dec; 28(10):993-1011. PubMed ID: 32378974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in polymeric micelles for drug delivery and tumor targeting.
    Kedar U; Phutane P; Shidhaye S; Kadam V
    Nanomedicine; 2010 Dec; 6(6):714-29. PubMed ID: 20542144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons.
    Majidinia M; Mirza-Aghazadeh-Attari M; Rahimi M; Mihanfar A; Karimian A; Safa A; Yousefi B
    IUBMB Life; 2020 May; 72(5):855-871. PubMed ID: 31913572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin.
    Xiong XB; Lavasanifar A
    ACS Nano; 2011 Jun; 5(6):5202-13. PubMed ID: 21627074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox-Activatable ATP-Depleting Micelles with Dual Modulation Characteristics for Multidrug-Resistant Cancer Therapy.
    Wang H; Li Y; Zhang M; Wu D; Shen Y; Tang G; Ping Y
    Adv Healthc Mater; 2017 Apr; 6(8):. PubMed ID: 28152267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.